Abstract
Introduction

Mesenchymal stem cells (MSCs) have the ability to differentiate into multiple lineages such as chondrocytes, osteocytes, adipocytes, myocytes and astrocytes, which are a potential
source of stem cells for cellular and genetic therapy [1, 2] . MSCs are found in the bone marrow but have also been isolated from other sites in the body such as adipose tissue and uterus [3] . The phenotype of MSCs is identified by the absence of the CD34 and CD45 haematopoietic cell markers and is positive for CD29, CD90 and CD105 [4] . MSCs [5] [6] [7] [8] . Koc [12] and prostaglandin E2 [13] have been involved in MSC-mediated immunosuppression, others report that IL-10 and TGF-␤ are not involved [14] . Meanwhile, the immunomodulatory effect of MSCs is not always achieved; in some cases, no effect is observed [15, 16] [19] . MSCs have a tropism for tumours [20] 
Cells and animal
MSCs were generated from bone marrow flushed out of tibia and femur of 4-6- (Fig. 1C) . (Fig. 2A) [21] . We examined whether iNOS and nitric oxide expression could increase in MSCs that were exposed to proinflammatory cytokines. MSCs were treated with IFN-␥ and TNF-␣, and the level of iNOS mRNA was assayed by real-time PCR. As was shown in the histogram and electropherogram, iNOS mRNA was up-regulated significantly in MSCs after being exposed to proinflammatory cytokines ( Figure 3A) . Figure 3B 
Real-time PCR
Results
MSCs pretreated by proinflammatory cytokines promotes the development of B16 melanoma cells in vivo
MSCs adhered to the plastic surface, presenting a small population of single cells which were spindle-shaped and contained one nucleus after 72 hrs of the primary culture. During 7 to 10 days after the initial plating, the cells looked like long spindle-shaped fibroblastic cells and began to form colonies. MSCs could differentiate into adipocytes and osteoblast-like cells. The surface antigen profile of mouse MSCs was detected by flow cytometry was positive for CD90, CD105 and CD29 and negative for CD34 and CD45 (Fig. 1A, B) To investigate whether BM-derived MSCs could favour the growth of B16 cells in inflammatory microenvironment, the MSCs, which were pre-incubated or not with the inflammatory cytokines IFN-␥ and TNF-␣, were subcutaneously co-injected with B16 cells in syngeneic C57BL/6 mice. Tumour nodules were firstly formed in the group of MSCs that was pre-incubated with the inflammatory cytokines IFN-␥ and TNF-␣. We found the growth of tumour that was mixed with MSCs was faster than that of B16 cells alone. Compared with MSCs unpretreated or pretreated with either IFN-␥ or TNF-␣, the ones pretreated with both inflammatory cytokines displayed the most striking tumour-stimulating effect
The rejection from Balb/c mice on B16 melanoma cells are reduced by the MSCs treated with proinflammatory cytokines
The immunosuppressive function of MSCs depended on proinflammatory cytokines treatment
We examined the effect of proinflammatory cytokines on immunosuppressive function of MSCs by co-cultured the MSCs with splenocytes. The splenocytes were activated with ConA followed by expansion with IL-2 for 3 days. We cocultured the activated splenocytes with MSCs that were pre-treated with or not with IFN-␥ and TNF-␣. The results showed that MSCs could not inhibit the proliferation of splenocytes. And if we pretreated MSCs with proinflammatory cytokines IFN-␥ and TNF-␣, the inhibitory effect of MSCs on splenocytes proliferation were arised (Fig. 2B). We also cocultured proinflammatory cytokines pretreated MSCs with activated splenocytes at graded ratios and found that the proliferation of splenocytes was blocked by MSCs at ratios as low as 1:50 (MSC to splenocyte) (Fig. 2C). These observations suggest that the MSCs immunosuppressive ability can be induced by proinflammatory cytokines IFN-␥ and TNF-␣.
MSCs exert immunosuppression requires nitric oxide
High concentrations Nitric oxide is known to inhibit T-cell responses
To investigate the role of nitric oxide, its production was shut down using siRNA to inhibit the expression of iNOS and a selective inhibitor of iNOS activity, 1400W. All the three candidate sequences could effectively inhibit iNOS expression in MSCs stimulated by IFN-␥ and TNF-␣ (data not shown). As shown in
IFN-␥ and TNF-␣, the expression of iNOS was markedly decreased in MSCs si-iNOS stimulated by both IFN-␥ and TNF-␣, which showed
a more than 90% inhibitory efficiency (Fig. 3C) . (Fig. 3D) 
In mixed cocultures of splenocytes and MSCs pre-stimulated by IFN-␥ and TNF-␣, splenocytes proliferation was restored to normal level by si-iNOS and 1400W
